Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis.
about
Human cytochrome b5 reductase: structure, function, and potential applications.Short- and long-term cure rates of short-duration trimethoprim-sulfamethoxazole treatment in female dogs with uncomplicated bacterial cystitisCYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection
P2860
Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evaluation of sulfonamide deto ...... -sulfamethoxazole prophylaxis.
@ast
Evaluation of sulfonamide deto ...... -sulfamethoxazole prophylaxis.
@en
Evaluation of sulfonamide deto ...... -sulfamethoxazole prophylaxis.
@nl
type
label
Evaluation of sulfonamide deto ...... -sulfamethoxazole prophylaxis.
@ast
Evaluation of sulfonamide deto ...... -sulfamethoxazole prophylaxis.
@en
Evaluation of sulfonamide deto ...... -sulfamethoxazole prophylaxis.
@nl
prefLabel
Evaluation of sulfonamide deto ...... -sulfamethoxazole prophylaxis.
@ast
Evaluation of sulfonamide deto ...... -sulfamethoxazole prophylaxis.
@en
Evaluation of sulfonamide deto ...... -sulfamethoxazole prophylaxis.
@nl
P2093
P2860
P1476
Evaluation of sulfonamide deto ...... m-sulfamethoxazole prophylaxis
@en
P2093
Brad S Kahl
Lauren A Trepanier
Mahmoud Abouraya
P2860
P304
P356
10.1111/J.1365-2125.2010.03889.X
P407
P577
2011-04-01T00:00:00Z